Shanghai Proton and Heavy Ion Hospital (SHPHI) is a modern and internationalized oncology center that integrates medical treatment, scientific research and teaching, and takes the international cutting-edge tumor radiation therapy technology - proton and heavy ion radiation therapy as the main treatment means, and it is also the first medical institution in China that possesses both proton and heavy ion radiation therapy technologies. The hospital is built by Shanghai Shenkang Hospital Development Center, and through the high degree of integration and resource sharing with Fudan University Cancer Hospital to carry out actual clinical operation, providing high-quality tumor diagnosis and treatment and early tumor screening services for the majority of patients.
Shanghai Proton Heavy Ion Hospital started its preparation in the 1990s, and the project was officially launched in 2003. Under the concern of the central leadership and the support of relevant state ministries and commissions, Shanghai has successfully built the first proton heavy ion hospital in China in the past ten years. 2014, the hospital successfully launched 35 clinical patient trials. 2015 May 8, the hospital officially operated. 2017 September, the hospital passed the Joint Commission on Accreditation of Healthcare Institutions (JCI), which is an international accreditation organization. In September 2017, the hospital was accredited by the Joint Commission on Accreditation of Healthcare Institutions International (JCI), becoming the first JCI-accredited proton heavy ion center in the world, and in January 2020, the hospital was listed as the Proton Heavy Ion Hospital affiliated with Fudan University.
The hospital is located in Zhangjiang Science City, Pudong New Area, Shanghai, with a total land area of 150 acres, a total construction area of 52,542 square meters in the first phase, 220 authorized beds, and 24 outpatient clinics. The hospital has introduced the proton/heavy ion system equipment “All-in-One” which can induce both proton and heavy ion rays, and is equipped with the international advanced pen scanning technology, respiratory gating technology and slideway CT equipment.
Over the past ten years of operation, the hospital has continued to optimize the treatment process and improve the efficiency of diagnosis and treatment. As of May 7, 2025, the cumulative number of discharged patients exceeded 8,039, with an average annual growth rate of 17.5%, and from 2021 to 2024, the annual treatment volume has steadily exceeded 1,000 cases for four consecutive years, which is the highest in the world in terms of “treatment volume in a single day, a single month, and a single year” for similar institutions. In 2024, 1,211 patients will be discharged from the hospital, an increase of 11% compared to 2023, which is a new record since the opening of the hospital and the highest among similar institutions in the world. The hospital is patient demand-oriented, highlighting the advantages of heavy ion technology, and taking nasopharyngeal cancer, intracranial skull base tumors, lung cancer, breast cancer, prostate cancer, pancreatic cancer, liver cancer, etc., which have the highest incidence rate in China and the advantages of proton heavy ion radiotherapy, as the key clinical diseases, with the number of patients of key diseases accounting for three quarters of the total number of patients treated by the hospital with proton heavy ion therapy.
In terms of clinical efficacy and control of toxic and side effects, the key diseases of the hospital have been comparable to or exceeded the advanced level of international similar institutions. Heavy ion treatment of recurrent nasopharyngeal carcinoma and lung cancer with small nodules has realized “zero breakthrough” in the field of international radiotherapy, and the 66 “Chinese programs” of particle diagnosis and treatment formed by independent innovation have broken the monopoly of developed countries in terms of “discourse power” and “monopoly”. "Since its operation, the hospital has accomplished a series of projects ranging from particle diagnosis and treatment to particle diagnosis and treatment. Since its operation, the hospital has completed the process of learning and catching up from the application of particle technology to become one of the advanced ranks of particle therapy in the world, and has become a leader in the field of innovation of clinical application of heavy ion technology, and the brand popularity and influence of “Shanghai Heavy Ion” has been continuously strengthened.
At present, the hospital is under the guidance and support of the relevant departments, with the creation of the National Cancer Medical Center as an opportunity, and actively promote the hospital's second-phase projects, and strive to establish the project as soon as possible, and start construction as soon as possible, so as to make greater contributions to the construction of Shanghai's international first-class medical center city.
Telephone: 021-38296600/ 021-38296601
Address：No.4365 Kangxin Highway, Pudong New Area, Shanghai (near Zhoudeng Highway)